226 related articles for article (PubMed ID: 17031262)
1. Angiotensin II type 1 receptor blocker attenuates exacerbated left ventricular remodeling and failure in diabetes-associated myocardial infarction.
Matsusaka H; Kinugawa S; Ide T; Matsushima S; Shiomi T; Kubota T; Sunagawa K; Tsutsui H
J Cardiovasc Pharmacol; 2006 Sep; 48(3):95-102. PubMed ID: 17031262
[TBL] [Abstract][Full Text] [Related]
2. Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction.
Hayashidani S; Tsutsui H; Shiomi T; Ikeuchi M; Matsusaka H; Suematsu N; Wen J; Egashira K; Takeshita A
Circulation; 2003 Oct; 108(17):2134-40. PubMed ID: 14517168
[TBL] [Abstract][Full Text] [Related]
3. AT2 receptor mediates the cardioprotective effects of AT1 receptor antagonist in post-myocardial infarction remodeling.
Oishi Y; Ozono R; Yoshizumi M; Akishita M; Horiuchi M; Oshima T
Life Sci; 2006 Dec; 80(1):82-8. PubMed ID: 17023005
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin converting enzyme inhibitor prevents left ventricular remodelling after myocardial infarction in angiotensin II type 1 receptor knockout mice.
Yoshiyama M; Nakamura Y; Omura T; Izumi Y; Matsumoto R; Oda S; Takeuchi K; Kim S; Iwao H; Yoshikawa J
Heart; 2005 Aug; 91(8):1080-5. PubMed ID: 16020603
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice.
Shiomi T; Tsutsui H; Matsusaka H; Murakami K; Hayashidani S; Ikeuchi M; Wen J; Kubota T; Utsumi H; Takeshita A
Circulation; 2004 Feb; 109(4):544-9. PubMed ID: 14744974
[TBL] [Abstract][Full Text] [Related]
6. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
See F; Thomas W; Way K; Tzanidis A; Kompa A; Lewis D; Itescu S; Krum H
J Am Coll Cardiol; 2004 Oct; 44(8):1679-89. PubMed ID: 15489104
[TBL] [Abstract][Full Text] [Related]
7. Allopurinol attenuates left ventricular remodeling and dysfunction after experimental myocardial infarction: a new action for an old drug?
Engberding N; Spiekermann S; Schaefer A; Heineke A; Wiencke A; Müller M; Fuchs M; Hilfiker-Kleiner D; Hornig B; Drexler H; Landmesser U
Circulation; 2004 Oct; 110(15):2175-9. PubMed ID: 15466649
[TBL] [Abstract][Full Text] [Related]
8. Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction.
Doerries C; Grote K; Hilfiker-Kleiner D; Luchtefeld M; Schaefer A; Holland SM; Sorrentino S; Manes C; Schieffer B; Drexler H; Landmesser U
Circ Res; 2007 Mar; 100(6):894-903. PubMed ID: 17332431
[TBL] [Abstract][Full Text] [Related]
9. Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction.
Kompa AR; See F; Lewis DA; Adrahtas A; Cantwell DM; Wang BH; Krum H
J Pharmacol Exp Ther; 2008 Jun; 325(3):741-50. PubMed ID: 18334667
[TBL] [Abstract][Full Text] [Related]
10. Adrenomedullin administration immediately after myocardial infarction ameliorates progression of heart failure in rats.
Nakamura R; Kato J; Kitamura K; Onitsuka H; Imamura T; Cao Y; Marutsuka K; Asada Y; Kangawa K; Eto T
Circulation; 2004 Jul; 110(4):426-31. PubMed ID: 15262849
[TBL] [Abstract][Full Text] [Related]
11. Adding angiotensin II type 1 receptor blockade to angiotensin-converting enzyme inhibition limits myocyte remodeling after myocardial infarction.
Kim YK; Mankad S; Kim SJ; Takagi G; Tamura T; Gerdes AM; Bishop SP; Kramer CM
J Card Fail; 2003 Jun; 9(3):238-45. PubMed ID: 12815575
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of mitochondrial peroxiredoxin-3 prevents left ventricular remodeling and failure after myocardial infarction in mice.
Matsushima S; Ide T; Yamato M; Matsusaka H; Hattori F; Ikeuchi M; Kubota T; Sunagawa K; Hasegawa Y; Kurihara T; Oikawa S; Kinugawa S; Tsutsui H
Circulation; 2006 Apr; 113(14):1779-86. PubMed ID: 16585391
[TBL] [Abstract][Full Text] [Related]
13. Losartan and acute myocardial infarction in insulin-resistant Zucker fatty rats: reduced ventricular arrhythmias and improved survival.
Pourdjabbar A; Parker TG; Desjardins JF; Nguyen QT; Tsoporis JN; Lapointe N; Rouleau JL
Can J Physiol Pharmacol; 2005 Nov; 83(11):989-98. PubMed ID: 16391707
[TBL] [Abstract][Full Text] [Related]
14. Postinfarction treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice.
Li Y; Takemura G; Kosai K; Yuge K; Nagano S; Esaki M; Goto K; Takahashi T; Hayakawa K; Koda M; Kawase Y; Maruyama R; Okada H; Minatoguchi S; Mizuguchi H; Fujiwara T; Fujiwara H
Circulation; 2003 May; 107(19):2499-506. PubMed ID: 12695295
[TBL] [Abstract][Full Text] [Related]
15. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
[TBL] [Abstract][Full Text] [Related]
16. Exercise training combined with angiotensin II receptor blockade limits post-infarct ventricular remodelling in rats.
Xu X; Wan W; Ji L; Lao S; Powers AS; Zhao W; Erikson JM; Zhang JQ
Cardiovasc Res; 2008 Jun; 78(3):523-32. PubMed ID: 18252761
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II type 1 receptor blocker attenuates myocardial remodeling and preserves diastolic function in diabetic heart.
Tsutsui H; Matsushima S; Kinugawa S; Ide T; Inoue N; Ohta Y; Yokota T; Hamaguchi S; Sunagawa K
Hypertens Res; 2007 May; 30(5):439-49. PubMed ID: 17587756
[TBL] [Abstract][Full Text] [Related]
18. Valsartan therapy in heart failure after myocardial infarction: the role of endothelial dependent vasorelaxation.
Thai H; Guarraia D; Johnson N; Goldman S; Gaballa MA
J Cardiovasc Pharmacol; 2007 Dec; 50(6):703-7. PubMed ID: 18091589
[TBL] [Abstract][Full Text] [Related]
19. Aliskiren in combination with valsartan exerts synergistic protective effects against ventricular remodeling after myocardial infarction in mice.
Higashikuni Y; Takaoka M; Iwata H; Tanaka K; Hirata Y; Nagai R; Sata M
Hypertens Res; 2012 Jan; 35(1):62-9. PubMed ID: 21833001
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of mitochondrial transcription factor a ameliorates mitochondrial deficiencies and cardiac failure after myocardial infarction.
Ikeuchi M; Matsusaka H; Kang D; Matsushima S; Ide T; Kubota T; Fujiwara T; Hamasaki N; Takeshita A; Sunagawa K; Tsutsui H
Circulation; 2005 Aug; 112(5):683-90. PubMed ID: 16043643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
